Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...
New research has revealed a confronting life-expectancy gap for people with intellectual disability in NSW, highlighting persistent and preventable inequities in health outcomes. The research, Life ...
The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...
Shocking inequalities experienced by men with learning disabilities when diagnosed with prostate cancer have been highlighted in a study by University of Manchester and Christie NHS Foundation Trust ...
The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital ...
Every time Hilary publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...
Following acceptance for admission to UTSA, the process of obtaining services and accommodations through Student Disability Services starts with submitting an online application and documentation of a ...
New Delhi: Most people associate cancer with visible symptoms. Pain, sudden weight loss, constant fatigue, or a lump that was not there before. What is less spoken about is how quietly many cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results